Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and
Mario Presti1, Emanuela Mazzon2, Maria Sofia Basile1
1Department of Biomedical and Biotechnological Sciences, Biological Tower, University of Catania, Catania I-95123, Italy.
Abstract:
The macrophage migration inhibition factor (MIF) is a cytokine with multiple biological functions, including the cancer-associated processes, cell cycle deregulation, angiogenesis and metastatization. The present study investigated the expression of MIF and its functionally associated genes (D-DT, CD74, CD44, CXCR2 and CXCR4) in glioblastoma multiforme (GBM). The data were obtained from The Cancer Genome Atlas databank, through the cBioportal web-based utility (cbioportal.org/). A significant increase was observed in the majority of these genes in GBM samples compared with lower grade gliomas, however no significant correlation among the selected genes and the overall survival of the patients was identified. In contrast, the expression of MIF exhibited a trend toward an increase in overall survival and a significant increase of MIF expression was observed in samples of patients who underwent neoadjuvant treatment. In conclusion these data indicate that MIF and its receptors are involved in GBM progression and maintenance. Deciphering the precise biological significance in GBM would favor the adoption of tailored approaches to modulate the function of MIF and its associated genes for the treatment of the disease.
Insights
Macrophage migration inhibition factor (MIF) and its associated genes are upregulated in glioblastoma multiforme (GBM). While not directly correlating with survival, MIF shows a trend towards increased survival and is elevated in patients receiving neoadjuvant treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Macrophage migration inhibition factor (MIF) is a cytokine implicated in cancer progression, including cell cycle deregulation, angiogenesis, and metastasis.
- Glioblastoma multiforme (GBM) is an aggressive brain tumor where understanding molecular drivers is crucial for effective treatment.
Purpose of the Study:
- To investigate the expression of MIF and its associated genes (D-DT, CD74, CD44, CXCR2, CXCR4) in GBM.
- To explore the correlation between these genes and patient overall survival.
- To analyze MIF expression in relation to neoadjuvant treatment in GBM patients.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) databank.
- Employed the cBioPortal web-based utility for data analysis.
- Compared gene expression in GBM samples versus lower-grade gliomas.
Main Results:
- A significant increase in the expression of most studied genes was observed in GBM compared to lower-grade gliomas.
- No significant correlation was found between the selected genes and overall patient survival.
- MIF expression showed a trend towards increased overall survival and was significantly elevated in patients who received neoadjuvant treatment.
Conclusions:
- MIF and its receptors play a role in the progression and maintenance of GBM.
- Further research into the biological significance of MIF in GBM could lead to targeted therapeutic strategies.
- Modulating MIF function may offer a novel approach for GBM treatment.
Related Concept Videos
Transcription Factors
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Gene Flow
Excitatory and Inhibitory Effects of Neurotransmitters
Migration


